Evidence map›Paper›PMID 18035408›Full record

ArticleCell2007

Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki, Megumi Narita, Tomoko Ichisaka, Kiichiro Tomoda, Shinya Yamanaka

3 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Cell, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 9,602 papers.

0numbers the graph read from it
0cells of the map it votes in
9,602citing papers in PubMed
345.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00801372 recruitingnot on this mapstarted 2008, after this paper: background citation

Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells

TypeobservationalSponsorHadassah Medical OrganizationRan2008 to 2030Enrolled1ConditionsPregnant, Healthy Females, Healthy Male Newborns
NCT00840567 naterminatednot on this mapstarted 2009, after this paper: background citation

Acquisition of Skin Biopsies and Blood Samples From Normal Volunteers and Patients With Benign, Inherited Hematologic Diseases for Research Purposes

TypeinterventionalSponsorWashington University School of MedicineRan2009 to 2010Enrolled7ConditionsAnemia, Sickle CellArmsSkin biopsy, Blood draw & sample
NCT02417311 unknown statusnot on this mapstarted 2014, after this paper: background citation

Individualized Early Risk Assessment for Heart Diseases

TypeobservationalSponsorUniversitätsklinikum Hamburg-EppendorfRan2014 to 2019Enrolled80ConditionsCardiomyopathy, Hypertrophic, Cardiomyopathy, DilatedArmsSkin biopsy, genotyping and disease phenotyping
3 · Its place in the literature

Who cites it

9,602 citing papers in PubMed, 20,020 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Human cardiovascular organoids: Biomedical applications and ethical challenges.American heart journal plus : cardiology research and practice · 2026
    Review
  20. Article

9,542 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Kazutoshi TakahashiDepartment of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Koji Tanabe
Mari Ohnuki
Megumi Narita
Tomoko Ichisaka
Kiichiro Tomoda
Shinya Yamanaka
Kyoto University · JPGladstone Institutes · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells. We previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors. Here, we demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc. Human iPS cells were similar to human embryonic stem (ES) cells in morphology, proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity. Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas. These findings demonstrate that iPS cells can be generated from adult human fibroblasts.

Indexed as

Cellular ReprogrammingGenes, mycTransduction, GeneticAdultAgedAnimalsBiomarkersCell DifferentiationCells, CulturedDNA-Binding ProteinsEmbryo, MammalianFemaleFibroblastsHMGB ProteinsHumansKruppel-Like Factor 4BiomarkersDNA-Binding ProteinsHMGB ProteinsKLF4 protein, humanKlf4 protein, mouseKruppel-Like Factor 4Kruppel-Like Transcription FactorsOctamer Transcription Factor-3SOX2 protein, humanSox2 protein, mouseSOXB1 Transcription FactorsTelomeraseTranscription Factors

Identifiers

PMID18035408
OpenAlexW2138977668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.